367 related articles for article (PubMed ID: 31132381)
1. The combination of exercise training and sodium-glucose cotransporter-2 inhibition improves glucose tolerance and exercise capacity in a rodent model of type 2 diabetes.
Linden MA; Ross TT; Beebe DA; Gorgoglione MF; Hamilton KL; Miller BF; Braun B; Esler WP
Metabolism; 2019 Aug; 97():68-80. PubMed ID: 31132381
[TBL] [Abstract][Full Text] [Related]
2. Combined effect of canagliflozin and exercise training on high-fat diet-fed mice.
Tanaka K; Takahashi H; Katagiri S; Sasaki K; Ohsugi Y; Watanabe K; Rasadul IMD; Mine K; Nagafuchi S; Iwata T; Eguchi Y; Anzai K
Am J Physiol Endocrinol Metab; 2020 Apr; 318(4):E492-E503. PubMed ID: 32017594
[TBL] [Abstract][Full Text] [Related]
3. Arterial pressure lability is improved by sodium-glucose cotransporter 2 inhibitor in streptozotocin-induced diabetic rats.
Yoshikawa T; Kishi T; Shinohara K; Takesue K; Shibata R; Sonoda N; Inoguchi T; Sunagawa K; Tsutsui H; Hirooka Y
Hypertens Res; 2017 Jul; 40(7):646-651. PubMed ID: 28202943
[TBL] [Abstract][Full Text] [Related]
4. Influence of Sodium Glucose Cotransporter 2 Inhibition on Physiological Adaptation to Endurance Exercise Training.
Newman AA; Grimm NC; Wilburn JR; Schoenberg HM; Trikha SRJ; Luckasen GJ; Biela LM; Melby CL; Bell C
J Clin Endocrinol Metab; 2019 Jun; 104(6):1953-1966. PubMed ID: 30597042
[TBL] [Abstract][Full Text] [Related]
5. A Low-Carbohydrate Diet Improves Glucose Metabolism in Lean Insulinopenic Akita Mice Along With Sodium-Glucose Cotransporter 2 Inhibitor.
Fujita Y; Atageldiyeva KK; Takeda Y; Yanagimachi T; Makino Y; Haneda M
Front Endocrinol (Lausanne); 2020; 11():601594. PubMed ID: 33362717
[TBL] [Abstract][Full Text] [Related]
6. The role of resistance and aerobic exercise training on insulin sensitivity measures in STZ-induced Type 1 diabetic rodents.
Hall KE; McDonald MW; Grisé KN; Campos OA; Noble EG; Melling CW
Metabolism; 2013 Oct; 62(10):1485-94. PubMed ID: 23810201
[TBL] [Abstract][Full Text] [Related]
7. Metformin supports the antidiabetic effect of a sodium glucose cotransporter 2 inhibitor by suppressing endogenous glucose production in diabetic mice.
Neschen S; Scheerer M; Seelig A; Huypens P; Schultheiss J; Wu M; Wurst W; Rathkolb B; Suhre K; Wolf E; Beckers J; Hrabé de Angelis M
Diabetes; 2015 Jan; 64(1):284-90. PubMed ID: 25071027
[TBL] [Abstract][Full Text] [Related]
8. Model-Based Evaluation of Proximal Sodium Reabsorption Through SGLT2 in Health and Diabetes and the Effect of Inhibition With Canagliflozin.
Brady JA; Hallow KM
J Clin Pharmacol; 2018 Mar; 58(3):377-385. PubMed ID: 29144539
[TBL] [Abstract][Full Text] [Related]
9. SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob
Adingupu DD; Göpel SO; Grönros J; Behrendt M; Sotak M; Miliotis T; Dahlqvist U; Gan LM; Jönsson-Rylander AC
Cardiovasc Diabetol; 2019 Feb; 18(1):16. PubMed ID: 30732594
[TBL] [Abstract][Full Text] [Related]
10. Sodium-Glucose Cotransporter 2 Inhibitor and a Low Carbohydrate Diet Affect Gluconeogenesis and Glycogen Content Differently in the Kidney and the Liver of Non-Diabetic Mice.
Atageldiyeva K; Fujita Y; Yanagimachi T; Mizumoto K; Takeda Y; Honjo J; Takiyama Y; Abiko A; Makino Y; Haneda M
PLoS One; 2016; 11(6):e0157672. PubMed ID: 27327650
[TBL] [Abstract][Full Text] [Related]
11. Combination of SGLT-2 Inhibitors and GLP-1 Receptor Agonists: Potential Benefits in Surrogate and Hard Endpoints.
Doumas M; Imprialos Κ; Stavropoulos K; Reklou A; Sachinidis A; Athyros VG
Curr Pharm Des; 2018; 24(17):1879-1886. PubMed ID: 29865997
[TBL] [Abstract][Full Text] [Related]
12. Voluntary exercise improves metabolic profile in high-fat fed glucocorticoid-treated rats.
Beaudry JL; Dunford EC; Leclair E; Mandel ER; Peckett AJ; Haas TL; Riddell MC
J Appl Physiol (1985); 2015 Jun; 118(11):1331-43. PubMed ID: 25792713
[TBL] [Abstract][Full Text] [Related]
13. Effect of canagliflozin on renal threshold for glucose, glycemia, and body weight in normal and diabetic animal models.
Liang Y; Arakawa K; Ueta K; Matsushita Y; Kuriyama C; Martin T; Du F; Liu Y; Xu J; Conway B; Conway J; Polidori D; Ways K; Demarest K
PLoS One; 2012; 7(2):e30555. PubMed ID: 22355316
[TBL] [Abstract][Full Text] [Related]
14. Exercise training improves basal blood glucose metabolism with no changes of cytosolic inhibitor B kinase or c-Jun N-terminal kinase activation in skeletal muscle of Otsuka Long-Evans Tokushima fatty rats.
Lee H; Chang H; Park JY; Kim SY; Choi KM; Song W
Exp Physiol; 2011 Jul; 96(7):689-98. PubMed ID: 21527545
[TBL] [Abstract][Full Text] [Related]
15. Effect of combination of chlorella intake and aerobic exercise training on glycemic control in type 2 diabetic rats.
Horii N; Hasegawa N; Fujie S; Uchida M; Iemitsu K; Inoue K; Iemitsu M
Nutrition; 2019; 63-64():45-50. PubMed ID: 30928787
[TBL] [Abstract][Full Text] [Related]
16. SHR3824, a novel selective inhibitor of renal sodium glucose cotransporter 2, exhibits antidiabetic efficacy in rodent models.
Yan PK; Zhang LN; Feng Y; Qu H; Qin L; Zhang LS; Leng Y
Acta Pharmacol Sin; 2014 May; 35(5):613-24. PubMed ID: 24786232
[TBL] [Abstract][Full Text] [Related]
17. Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment.
D'Onofrio N; Sardu C; Trotta MC; Scisciola L; Turriziani F; Ferraraccio F; Panarese I; Petrella L; Fanelli M; Modugno P; Massetti M; Marfella LV; Sasso FC; Rizzo MR; Barbieri M; Furbatto F; Minicucci F; Mauro C; Federici M; Balestrieri ML; Paolisso G; Marfella R
Mol Metab; 2021 Dec; 54():101337. PubMed ID: 34500107
[TBL] [Abstract][Full Text] [Related]
18. TS-071 is a novel, potent and selective renal sodium-glucose cotransporter 2 (SGLT2) inhibitor with anti-hyperglycaemic activity.
Yamamoto K; Uchida S; Kitano K; Fukuhara N; Okumura-Kitajima L; Gunji E; Kozakai A; Tomoike H; Kojima N; Asami J; Toyoda H; Arai M; Takahashi T; Takahashi K
Br J Pharmacol; 2011 Sep; 164(1):181-91. PubMed ID: 21410690
[TBL] [Abstract][Full Text] [Related]
19. The effects of voluntary exercise and prazosin on capillary rarefaction and metabolism in streptozotocin-induced diabetic male rats.
Dunford EC; Leclair E; Aiken J; Mandel ER; Haas TL; Birot O; Riddell MC
J Appl Physiol (1985); 2017 Mar; 122(3):492-502. PubMed ID: 27932675
[TBL] [Abstract][Full Text] [Related]
20. SGLT2 inhibition reprograms systemic metabolism via FGF21-dependent and -independent mechanisms.
Osataphan S; Macchi C; Singhal G; Chimene-Weiss J; Sales V; Kozuka C; Dreyfuss JM; Pan H; Tangcharoenpaisan Y; Morningstar J; Gerszten R; Patti ME
JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30843877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
